Compare GOOS & CERT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GOOS | CERT |
|---|---|---|
| Founded | 1957 | 2008 |
| Country | Canada | United States |
| Employees | 4289 | N/A |
| Industry | | Retail: Computer Software & Peripheral Equipment |
| Sector | | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 987.0M | 860.9M |
| IPO Year | 2016 | 2020 |
| Metric | GOOS | CERT |
|---|---|---|
| Price | $10.01 | $6.14 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 5 | 10 |
| Target Price | ★ $12.60 | $11.67 |
| AVG Volume (30 Days) | 638.6K | ★ 3.6M |
| Earning Date | 05-20-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 87.50 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $418,838,000.00 |
| Revenue This Year | $12.21 | $4.18 |
| Revenue Next Year | $5.16 | $5.39 |
| P/E Ratio | $75.22 | ★ N/A |
| Revenue Growth | N/A | ★ 8.75 |
| 52 Week Low | $9.30 | $4.45 |
| 52 Week High | $15.43 | $13.88 |
| Indicator | GOOS | CERT |
|---|---|---|
| Relative Strength Index (RSI) | 42.31 | 61.01 |
| Support Level | $9.30 | $5.93 |
| Resistance Level | $14.45 | $6.47 |
| Average True Range (ATR) | 0.46 | 0.31 |
| MACD | 0.02 | 0.14 |
| Stochastic Oscillator | 31.36 | 99.37 |
Canada Goose Holdings Inc is a Canada-based company that designs, manufactures, distributes, and retails premium outerwear for men, women, and children. It operates business through three segments namely, Wholesale; Direct to Consumer (DTC), and Other. The DTC segment, which is the key revenue driver, comprises sales through country-specific e-commerce platforms and its company-owned retail stores located in luxury shopping locations. The Wholesale segment comprises sales made to a mix of retailers and international distributors, who are partners that have exclusive rights to an entire market, and travel retail locations. Geographically, it has a presence in Canada, the United States, North America, Greater China, Asia-Pacific, and Europe, the Middle East, and Africa.
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval, and increase patient access to medicines. The company has its business presence in the Americas, which is also its key revenue-generating market, EMEA, and the Asia Pacific region.